Skip to main content
Log in

Metallothionein 1F mRNA Expression Correlates with Histological Grade in Breast Carcinoma

  • Conference Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Immunohistochemical expression of metallothioneins (MTs), a group of intracellular metal-binding proteins, is well documented in breast cancer. However, there is a paucity of information on the expression of the different MT isoforms in breast cancer tissues. The dichotomous association of MT overexpression with tumour types and progression led us to examine the role of the MT-1F mRNA isoform in breast cancer. We evaluated MT expression in 48 primary invasive ductal breast cancer tissues by immunohistochemistry, and the corresponding MT-1F mRNA expression via a semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) assay. The specificity of the RT-PCR products was confirmed by direct cycle sequencing and restriction enzyme digestion. Immunohistochemical analysis of MT revealed a significantly higher MT expression in histological grade 3 tumours as compared to grade 1 and 2 tumours (p=0.021). Similarly, MT-1F mRNA expression was found to be significantly higher in grade 3 tumours (p<0.001). The results suggest that the MT-1F isoform influences histological differentiation in invasive ductal breast cancer. The converse is also true in that the histological grade may determine the level of MT-1F expression in breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kägi JHR, Schaffer A: Biochemistry of metallothionein. Biochemistry 27: 8509-8515, 1998

    Google Scholar 

  2. Kägi JHR: Overview of metallothionein. Meth Enzymol 205: 613-626, 1991

    Google Scholar 

  3. Schwarz MA, Lazo JS, Yalowich JC, Allen WP, Whitmore M, Bergonia HA, Tzeng E, Billiar TR, Robbins PD, Lancaster JR Jr, Pitt BR: Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. Proc Natl Acad Sci USA 92: 4452-4456, 1995

    Google Scholar 

  4. Jasani B, Schmid KW: Significance of metallothionein overexpression in human tumours. Histopathology 31: 211-214, 1997

    Google Scholar 

  5. Ofner D, Maier H, Riedmann B, Bammer T, Rumer A, Winde G, Bocker W, Jasani B, Schmid KW: Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumour stage and patient survival. Virchows Arch A 425: 491-497, 1994

    Google Scholar 

  6. Giuffre G, Barresi G, Sturniolo GC, Sarnelli R, D'Inca R, Tuccari G: Immunohistochemical expression of metallothione in in normal human colorectal mucosa, in adenomas, and in adenocarcinomas and their associated metastases. Histopathology 29: 347-354, 1996

    Google Scholar 

  7. Bahnson RR, Banner BF, Ernstoff MS, Lazo JS, Cherian MG, Banerjee D, Chin JL: Immunohistochemical localization of metallothionein in transitional cell carcinoma of the bladder. J Urol 146: 1518-1520, 1991

    Google Scholar 

  8. Schmid KW, Ellis IO, Gee JM, Darke BM, Lees WE, Kay J, Cryer A, Stark JM, Hittmair A, Ofner D, Margreiter R, Daxenhichler G, Nicholson RI, Bier B, Bocker W, Jasani B: Presence and possible significance of immunocytochemically demonstrable metallothionein overexpression in primary invasive ductal carcinoma of the breast. Virchows Arch A 422: 153-159, 1993

    Google Scholar 

  9. Haerslev T, Jacobsen K, Nedergaard L, Zedeler K: Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastases. Path Res Pract 190: 675-681, 1994

    Google Scholar 

  10. Haerslev T, Jacobsen K, Zedeler K: The prognostic significance of immunocytochemically detectable metallothionein in primary breast carcinomas. Acta Path Microbiol Immunol Scand 103: 279-285, 1995

    Google Scholar 

  11. Lim K, Evans A, Adams M, Fish R, Dhundee J, Dallimore N, Jasani B: Association of immunohistochemically detectable metallothionein (IDMT) expression with malignant transformation in cervical neoplasia. J Pathol 178 (suppl.): 48A, 1996

    Google Scholar 

  12. McCluggage WG, Maxwell P, Hamilton PW, Jasani B: High metallothione in expression is associated with features predictive of aggressive behaviour in endometrial carcinoma. Histopathology 34: 51-55, 1999

    Google Scholar 

  13. Ohshio G, Imamura T, Okada N, Wang ZH, Yamaki K, Kyogoku T, Suwa H, Yamabe H, Imamura M: Immunohistochemical study of metallothionein in pancreatic carcinomas. J Cancer Res Clin Oncol 122: 351-355, 1996

    Google Scholar 

  14. Schmidt CJ, Hamer DH: Cell specificity and an effect of ras on human metallothionein gene expression. Proc Natl Acad Sci USA 83: 3346-3350, 1986

    Google Scholar 

  15. Elston CW, Ellis IO: Systemic Pathology. Vol. 13 The Breast, 3rd edn. Churchill Livingstone, Edinburgh, 1998, pp 365-383

    Google Scholar 

  16. Jin R, Bay BH, Chow VTK, Tan PH, Lin VCL: Metallothionein 1E mRNA is highly expressed in estrogen receptornegative human invasive ductal breast cancer. Br J Cancer 83: 319-323, 2000

    Google Scholar 

  17. Mididoddi S, McGuirt JP, Sens MA, Todd JH, Sens DA: Isoform-specific expression of metallothionein mRNA in the developing and adult human kidney. Toxicol Lett 685: 17-27, 1996

    Google Scholar 

  18. Abdel-Mageed AB, Agrawal KC: Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther 4: 199-207, 1997

    Google Scholar 

  19. Jin R, Bay B, Tan P, Tan BK: Metallothionein expression and zinc levels in invasive ductal breast carcinoma. Oncol Rep 6: 871-875, 1999

    Google Scholar 

  20. Jayasurya A, Bay BH, Yap WM, Tan NG: Correlation of metallothionein expression with apoptosis in nasopharyngeal carcinoma. Br J Cancer 82: 1198-1203, 2000

    Google Scholar 

  21. Friedline JA, Garrett SH, Somji S, Todd JH, Sens DA: Differential expression of the MT-1E gene in estrogen-receptorpositive and-negative human breast cancer cell lines. Am J Pathol 152: 23-27, 1998

    Google Scholar 

  22. Fresno M, Wu W, Rodriguez JM, Nadji M: Localization of metallothionein in breast carcinomas. An immunohistochemical study. Virchows Archiv A 423: 215-219, 1993

    Google Scholar 

  23. Douglas-Jones AG, Schmid KW, Bier B, Horgan K, Lyons K, Dallimore ND, Moneypenny IJ, Jasani B: Metallothionein expression in duct carcinoma in situ of the breast. Hum Pathol 26: 217-222, 1995

    Google Scholar 

  24. Lin VCL, Ng EH, Aw SE, Tan MGK, Ng EHL, Chan VSW, Ho GH: Progestins inhibit the growth of MDA-MB-231 cells transfected with progesterone receptor complementary DNA. Clin Cancer Res 5: 395-403, 1999

    Google Scholar 

  25. Lin VCL, Ng EH, Aw SE, Tan MGK, Ng EHL, Bay BH: Progesterone induces focal adhesion in breast cancer cells MDA-MB-231 transfected with progesterone receptor cDNA. Mol Endocrinol 14: 348-358, 2000

    Google Scholar 

  26. Gilbert SF: Developmental Biology. 5th edn., Sinauer Associates, Massachusetts, 1997, pp 391-504

    Google Scholar 

  27. Schmidt CJ, Jubier MF, Hamer DH: Structure and expression of two human metallothionein-I isoform genes and a related pseudogene. J Biol Chem 260: 7731-7737, 1985

    Google Scholar 

  28. Varshney U, Jahroudi N, Foster R, Gedamu L: Structure, organization, and regulation of human metallothionein IF gene: differential and cell-type-specific expression in response to heavy metals and glucocorticoids. Mol Cell Biol 6: 26-37, 1986

    Google Scholar 

  29. Yang YY, Woo ES, Reese CE, Bahnson RR, Saijo N, Lazo JS: Human metallothionein isoform gene expression in cisplatinsensitive and resistant cells. Mol Pharmacol 45: 453-460, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jin, R., Bay, BH., Chow, V.TK. et al. Metallothionein 1F mRNA Expression Correlates with Histological Grade in Breast Carcinoma. Breast Cancer Res Treat 66, 265–272 (2001). https://doi.org/10.1023/A:1010658907462

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1010658907462

Navigation